Filar, I., Witkowski, M., Ryżewska, W. and Robak, T. 2024. Recombinant ADAMT S-13 as a new alternative for the patients with congenital thrombocytopenic purpura. OncoReview. 14, 3(55) (Dec. 2024), 59-63. DOI:https://doi.org/10.24292/01.OR.143301224.